PT Indofarma Tbk reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was IDR 445,701.94 million compared to IDR 904,897.23 million a year ago. Net loss was IDR 191,699.89 million compared to IDR 183,110.19 million a year ago.

Basic loss per share from continuing operations was IDR 61.85 compared to IDR 59.08 a year ago.